Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10479491rdf:typepubmed:Citationlld:pubmed
pubmed-article:10479491lifeskim:mentionsumls-concept:C1512288lld:lifeskim
pubmed-article:10479491lifeskim:mentionsumls-concept:C0280631lld:lifeskim
pubmed-article:10479491lifeskim:mentionsumls-concept:C0144576lld:lifeskim
pubmed-article:10479491lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:10479491lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:10479491pubmed:issue3lld:pubmed
pubmed-article:10479491pubmed:dateCreated1999-10-26lld:pubmed
pubmed-article:10479491pubmed:abstractTextThe aim of this study was to determine the activity of paclitaxel in chemotherapy-naive patients with advanced or recurrent uterine leiomyosarcoma.lld:pubmed
pubmed-article:10479491pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10479491pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10479491pubmed:languageenglld:pubmed
pubmed-article:10479491pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10479491pubmed:citationSubsetIMlld:pubmed
pubmed-article:10479491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10479491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10479491pubmed:statusMEDLINElld:pubmed
pubmed-article:10479491pubmed:monthSeplld:pubmed
pubmed-article:10479491pubmed:issn0090-8258lld:pubmed
pubmed-article:10479491pubmed:authorpubmed-author:BlessingJ AJAlld:pubmed
pubmed-article:10479491pubmed:authorpubmed-author:SuttonGGlld:pubmed
pubmed-article:10479491pubmed:authorpubmed-author:BallHHlld:pubmed
pubmed-article:10479491pubmed:copyrightInfoCopyright 1999 Academic Press.lld:pubmed
pubmed-article:10479491pubmed:issnTypePrintlld:pubmed
pubmed-article:10479491pubmed:volume74lld:pubmed
pubmed-article:10479491pubmed:ownerNLMlld:pubmed
pubmed-article:10479491pubmed:authorsCompleteYlld:pubmed
pubmed-article:10479491pubmed:pagination346-9lld:pubmed
pubmed-article:10479491pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:meshHeadingpubmed-meshheading:10479491...lld:pubmed
pubmed-article:10479491pubmed:year1999lld:pubmed
pubmed-article:10479491pubmed:articleTitlePhase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study.lld:pubmed
pubmed-article:10479491pubmed:affiliationDivision of Gynecologic Oncology, Indiana University Medical School, Indianapolis, Indiana, 46202, USA.lld:pubmed
pubmed-article:10479491pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10479491pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10479491pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10479491pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10479491lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10479491lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10479491lld:pubmed